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Development of metanephric kidney begins with ureteric bud outgrowth from the Wolffian duct (WD). GDNF is believed to be a crucial
positive signal in the budding process, but the negative regulation of this process remains unclear. Here, we examined the role of activin A, a
member of TGF-β family, in bud formation using an in vitro WD culture system. When cultured with the surrounding mesonephros, WDs formed
many ectopic buds in response to GDNF. While the activin signaling pathway is normally active along the non-budding WD (as measured by
expression of activin A and phospho-Smad2/3), activin A was absent and phospho-Smad2/3 was undetectable in the ectopic buds induced by
GDNF. To examine the role of activin A in bud formation, we attempted to inactivate activin action. Interestingly, the addition of neutralizing anti-
activin A antibody potentiated GDNF action. To further clarify the role of activin A, we also tested the effect of activin blockade on the WD
cultured in the absence of mesonephros. WDs without mesonephros did not form ectopic buds even in the presence of GDNF. In contrast,
blockade of activin action with a variety of agents acting through different mechanisms (natural antagonist, neutralizing antibodies, siRNA)
enabled GDNF to induce ectopic buds. Inhibition of GDNF-induced bud formation by activin A was accompanied by inhibition of cell
proliferation, reduced expression of Pax-2, and decreased phosphorylation of PI3-kinase and MAP kinase in the WD. Our data suggest that activin
A is an endogenous inhibitor of bud formation and that cancellation of activin A autocrine action may be critical for the initiation of this process.
© 2006 Elsevier Inc. All rights reserved.Keywords: Wolffian duct; Activin; Ureteric bud outgrowth; Smad; BMP4; Mesonephros; Ectopic bud; Nephrogenesis; AutocrineIntroduction
The embryonic kidney forms through reciprocal interac-
tions between the metanephric mesenchyme and the ureteric
bud (UB) (Saxén, 1987). The metanephric mesenchyme
localizes at the caudal end of the intermediate mesoderm
and induces the UB from the neighboring Wolffian duct
(WD). The invading UB induces the metanephric mesen-
chyme to aggregate and epithelialize to form renal vesicles,
which undergoes complex morphogenetic changes to form the
mature nephron, the functional unit of the kidney (Shah et al.,
2004). Ectopic budding of the UB from the WD leads to many
congenital anomalies of the kidney and urinary tract such as⁎ Corresponding author. Fax: +1 858 822 3481.
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doi:10.1016/j.ydbio.2006.03.011hypoplastic kidney, ectopia of the ureterovesical orifice,
urinary outflow obstruction, and/or reflux (Ichikawa et al.,
2002; Pohl et al., 2002). Elucidation of the budding
mechanism is essential for understanding how these abnor-
malities of the kidney and urinary tract develop. However, the
mechanisms behind this process have only been partly
elucidated. It is currently thought that UB emerges from the
WD in response to glial-cell-derived neurotrophic growth
factor (GDNF) produced by metanephric mesenchyme
(Shakya et al., 2005). Recent evidence indicates that GDNF
action is tightly regulated by several factors or signaling
systems during the UB outgrowth from the WD. For example,
mice lacking Sprouty1 (the receptor tyrosine kinase antago-
nist) have supernumerary ureteric buds. This phenotype was
caused by enhanced sensitivity of the WD to GDNF, resulting
in the development of multiple ureters and multiplex kidneys
(Basson et al., 2005). In Slit/Robo knockout mice, it was also
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maintained in anterior nephrogenic mesenchyme, resulting in
the development of supernumerary ureteric buds (Griesham-
mer et al., 2004). These data suggest that negative regulatory
systems are also operative in this process.
Activins are multifunctional cytokines structurally related to
transforming growth factor (TGF)-β (de Caestecker, 2004).
Like other members of the TGF-β superfamily, activins
modulate cell proliferation, induce differentiation, and are
involved in organogenesis and tissue remodeling (Maeshima et
al., 2001a; Welt et al., 2002). Activins are dimeric proteins, and
subunits of activin are expressed in various organs (ten Dijke
and Hill, 2004). An important modulator of activin action is
follistatin (Nakamura et al., 1990), which specifically binds to
activins and related ligands with high affinity and blocks their
action (Nakamura et al., 1990; Shimonaka et al., 1991). In
general, activins exert their actions as autocrine or paracrine
factors (Welt et al., 2002). Among activins, activin A is
expressed in the kidney (Tuuri et al., 1994). Follistatin is also
expressed in this organ abundantly (Shimasaki et al., 1989).
Activin A blocks branching morphogenesis of the developing
kidney collecting system (Bush et al., 2004; Maeshima et al.,
2003; Ritvos et al., 1995) and also inhibits tubulogenesis in
cultured renal epithelia cells (Maeshima et al., 2000b) as do
TGF-βs (Sakurai and Nigam, 1997; Santos and Nigam, 1993),
raising the possibility of a potential role for activin A as one of
the negative regulators of kidney development.
Here, we demonstrate the importance of activin A in UB
emergence from the WD. When cultured in the absence of
mesonephros, WDs did not form ectopic buds in the presence of
GDNF. However, perturbation of activin action with a number
of mechanistically distinct agents (antagonist, neutralizing
antibodies, siRNA) allowed GDNF to induce ectopic budding.
The activin signaling pathway is normally active in the WD but
was inactivated in the ectopic buds induced by GDNF. Our data
suggest that activin A acts as an endogenous inhibitor of UB
outgrowth from the WD. GDNF may induce UB outgrowth
from the WD by canceling the action of activin A.
Materials and methods
Reagents
Recombinant human activin A, activin B, activin AB, TGF-β1, BMP-2,
BMP-4, BMP-7, noggin, chordin, and rat glial-cell-line-derived neurotrophic
factor (GDNF), goat anti-βA subunit of activin A antibody, goat anti-activin
receptor type IB (ActRIB) antibody, goat anti-activin receptor type IIA
(ActRIIA) antibody, goat anti-activin receptor type IIB (ActRIIB) antibody,
goat anti-BMP4 antibody, and goat anti-TGF-β (1,2,3) antibody were from
R&D systems (Minneapolis, MN). Goat polyclonal antibodies against Smad2/3
or Smad1/5/8 and rabbit anti-β actin antibody were obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Rabbit polyclonal antibodies against
phospho-Smad2/3, phospho-Akt phospho-extracellular signal regulated kinase
(ERK), and phospho-p38 were from Cell Signaling Technology (Beverly, MA).
Bromodeoxyuridine (BrdU) was from Sigma (St. Louis, MO). FITC-conjugated
or Rhodamine-conjugated Dolichos Biflorus (DB) lectin was from Vector
Laboratories (Burlingame, CA). Fetal bovine serum (FBS) was from Biowhit-
taker (Walkersville, MD). DAPI (4′, 6-diamino-2′-phenylindole dihydrochlor-
ide) was from Calbiochem (San Diego, CA). DMEM/F12 was purchased from
GIBCO-BRL (Grand Island, NY).Isolation and culture of Wolffian duct
Timed pregnant Sprague–Dawley rats (Harlan, Indianapolis, IN) at day 13
of gestation (day 0 being the day of appearance of the vaginal plug) were used
for experiments. The embryos were dissected free of surrounding tissues, and
the WD with surrounding mesonephros were isolated under a stereomicroscope.
When WDs were cultured in the absence of mesonephros, surrounding
mesonephros was removed from the WD with fine forceps, but there were
still a small number of mesodermal cells attached on the WD. Isolated tissues
were applied to the top of Transwell filters (0.4 μm pore size) (Costar,
Cambridge, MA) placed within individual wells of a 12-well tissue culture dish.
The isolated tissues were cultured in DMEM/F12 supplemented with 10% FBS
at 37°C and 5% CO2/100% humidity. After the indicated number of days,
cultures were fixed with 4% paraformaldehyde (PFA) and used for histological
analysis. For the bead experiments, heparin acrylamide beads (Sigma, St. Louis,
MO) were incubated in 10 μg/ml of recombinant Follistatin for 1 h on ice and
washed briefly in phosphate-buffered saline (PBS) before placing on organ
cultures. The care and use of animals described in this study conform to the
procedures of the laboratory's Animal Protocol approved by the Animal
Subjects Program of the University of California, San Diego.
Quantification of bud formation
For quantification of bud formation, the number of WDs in which ectopic
buds was observed regardless of bud number or shape was counted and was
expressed as the percentage of total number of WDs used (n = 4–5). Values are
the mean ± SE of three to five separate experiments.
DB lectin staining
To visualize the WD and ectopic budding structures specifically, FITC-
conjugated or Rhodamine-conjugated Dolichos Biflorus (DB) lectin staining
was performed as described previously (Qiao et al., 1999).
Immunohistochemistry
Isolated WDs with mesonephros were cultured on Transwell filter in the
presence of the indicated growth factors. After the indicated days, cultures were
fixed with 4% PFA and were processed for paraffin-embedded or frozen
sections. Immunofluorescent staining was performed as described previously
(Maeshima et al., 2002).
Detection of cell proliferation and apoptosis
Cultured WDs were labeled with 100 μM BrdU for 3 h. After extensive
washing with PBS, the WDs were fixed with 4% PFA. Cell proliferation was
analyzed by BrdU labeling using a cell proliferation kit (Amersham, Piscataway,
NJ) (Maeshima et al., 2001b). For identification of nuclei with DNA strand
breaks at the cellular level, the terminal deoxynucleotidyl transferase-mediated
dUTP-nick-end-labeling (TUNEL) staining was performed using a DeadEnd™
Fluorometric TUNEL System (Promega, Madison, WI) according to the
manufacturer's instruction. Quantification of BrdU-positive or TUNEL-positive
cells was performed by counting positive nuclei in total cells (DAPI-positive
nuclei) from selected fields under fluorescent microscope at ×400 magnification.
Values are the mean ± SE (n = 5).
Reverse transcriptase-PCR
Total RNA was isolated with the TRIzol Reagent (Life Technologies/BRL)
from WDs or surrounding mesonephros. First-strand cDNAwas made from total
RNA using Superscript Preamplification System (Life Technologies/BRL)
according to the manufacturer's instruction. Contaminated genomic DNA was
removed with RNase-free deoxyribonuclease (DNase). Five micrograms of
DNase-treated RNA was incubated with 1 μl of oligodT at 70°C for 10 min.
Two-microliter 10× PCR buffer (200 mMTris–HCl, pH 8.4, 500 mMKCl), 1 μl of
DTT (0.1 M), 2 μl of dNTP mix (10 mM), and 2 μl of MgCl2 (25 mM) were added
to each reaction. After incubation for 5 min at 42°C, 1 μl of reverse transcriptase
(RT) was added. Samples were incubated at 42°C for 50 min and then at 70°C for
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37°C for 20 min. PCR was performed with the primers as follows: rat α subunit
(sense and antisense: 5′-AGGTGGGGGTCCTGGAATAAGG-3′ and 5′-
GGTGGGTCAACAGAGGGAAAGC-3′, respectively), rat βA subunit (sense
and antisense: 5′-GGACCTAACTCTCAGCCAGAGATG-3′ and 5′-TCTCA-
AAATGCAGTGTCTTCCTGG-3′, respectively), rat βB subunit (sense and
antisense: 5′-CACGGTGACAGGTGGAATGTG-3′ and 5′-TGGAAGG-
AGGAGGCTGAACC-3′, respectively), rat βC subunit (sense and antisense:
5′-GGTAAGAGTTGAAGGCAAGCATCG-3′ and 5′-ATAGTAGAGC-
AAAGACAGAGGGCG-3′, respectively), rat βE subunit (sense and antisense:
5′-GCTTGCGGAGTGAGGAATCTG-3′ and 5′-TGGGGACACAGCAGGAA-
GAAC-3′, respectively), rat activin type I receptor (sense and antisense: 5′-GGT-
CTATGAGCAGGGGAAGATGAC-3′ and 5′-ACATTTTCGCCTTGCCAGC-3′,
respectively), rat activin type II receptor (sense and antisense: 5′-AGATGGAAGT-
CACACAGCCCAC-3′ and 5′-CAACACTGGTGCCTCTTTTCTCTG-3′, respec-
tively), rat GAPDH (sense and antisense: 5′-CATGACCACAGTCCATGCCATC-3′
and 5′-CACCCTGTTGCTGTAGCCATATTC-3′, respectively). Reactions included
5 μl of a 10× PCR buffer, 2 μl ofMgCl2 (50mM), 1 μl of dNTPmix, 1 μl of 3′primer,
1 μl of 5′primer, 0.5 μl of Taq polymerase, and 1 μl of cDNA. Samples were incubated
at 94°C for 5min followed by the indicated cycles of 30 s at 94°C, 30 s at 58°C, 90 s at
72°C, and final extension at 72°C for 10 min in a PTC-100 Peltier Thermal Cycler
(Bio-Rad Laboratories, Inc. Waltham, MA). PCR reactions were 30 cycles for inhibin
subunits, activin type I and type II receptor and 20 cycles for GAPDH. Reverse
transcription reaction products without reverse transcriptase were used as negative
controls. Rat ovary cDNA or rat hepatocyte cDNA was used as positive controls in
each experiment. Reactions were repeated at least twice.
Transfection of small interference (si) RNA
Transfection of siRNA of inhibin βA was performed using Lipo-
fectamine2000 (Invitrogen, CA) according to the manufacturer's instructions.
Briefly, WDs were isolated the day before transfection and cultured on Transwell
filter in DMEM/F12 containing 10% FBS for 24 h. On the day of transfection,
siRNA and Lipofectamine2000 were separately diluted in Opti-MEM I without
serum and incubated at room temperature for 5 min. They were mixed and
incubated at room temperature for 20 min. Culture medium was changed to
serum-free medium. The mixture of siRNA and Lipofectamine2000 was overlaid
on the WDs. After incubation for 8 h at 37°C, FBS was added into the culture
medium without removing the transfection mixture. The expression of inhibin βA
was examined by Western blotting at 2 days after transfection. Mixture of 4
different custom-made siRNA of inhibinβA (No. 1 sense: GGAGUGAACUGU
UGC UAU CUU; antisense: GAU AGC AAC AGU UCA CUC CUU, No. 2
sense: GAA AGC UUC AUG UGG GUA AUU; antisense: UUA CCC ACA
UGA AGC UUU CUU, No. 3 sense: GGA UUU CUG UUG GCA AGU UUU;
antisense: AAC UUG CCA ACA GAA AUC CUU, No. 4 sense: ACG GGU
AUG UGG AGA UAG AUU; antisense: UCU AUC UCC ACA UAC CCG
UUU) and control siRNAwas purchased from Dharmacon (Lafayette, CO).
Western blot analysis
Tissues were washed with PBS and suspended in sample buffer
containing 50 mM Tris–HCl (pH 6.8), 2% sodium dodecyl sulfate (SDS),
1% glycerol, and 1 mM phenylmethylsulfonyl fluoride (PMSF). After
ultrasonication and centrifugation, supernatant was collected, and the protein
concentration was determined with the BCA protein assay kit (PIERCE,
Rockford, IL). Twenty micrograms of protein from each sample was
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using
NuPAGE Novex Bis–Tris Gels (10%) (Invitrogen, Carlsbad, CA) and
transferred to a Nitrocellulose membrane (Hybond™-C, Amersham Bios-
ciences, Piscataway, NJ). To reduce nonspecific antibody binding, the
membrane was blocked with Tris-buffered saline (TBS)-T (20 mM Tris–
HCl, 150 mM NaCl, and 0.1% Tween 20) containing 3% bovine serum
albumin (BSA), incubated with primary antibody for 2 h, and washed with
TBS-T. After incubation with peroxidase-labeled secondary antibody for 2 h,
the membrane was washed with TBS-T and analyzed by exposure to X-ray
film using Supersignal West Pico Chemiluminescent Substrate (PIERCE,
Rockford, IL). The relative density of the band was quantified using an
image analysis software (Image J 1.34s, NIH).Real-time PCR
Real-time PCR was performed by the ABI 7300 Real-time PCR System
(Applied Biosystems, Foster City, CA, USA). Reactions included 25 μl of a
Platinum® SYBR® Green qPCR SuperMix-UDG with ROX (Invitrogen,
Carlsbad, CA), 1 μl 3′ primer, 1 μl 5′ primer, and 5 μl cDNA. Samples were
incubated at 50°C for 2 min, then at 95°C for 5 min, followed by 45 cycles of
15 s at 95°C, 30 s at 56°C, and 30 s at 72°C. The expression of the βA subunit
and GAPDH in each sample was quantified in separate tubes with the following
primers: rat βA subunit (sense and antisense: 5′-CCGAGGAAATGGGCTT-
GAAGG-3′ and 5′-CAATCCGCACATCCAGGGAAC-3′, respectively), rat
GAPDH (sense and antisense: 5′-AAGGTCATCCCAGAGCTGAA-3′ and 5′-
CCTGCTTCACCACCTTCTTG-3′). Gels of the PCR products after quantifi-
cation of the indicated genes by real-time PCR showed single bands (βA
subunit, 153 base pair, and GAPDH, 139 base pair, respectively) in which the
band size was the same as expected (data not shown).
Statistical analysis
The differences between means were compared by Student's t test, with P
values of <0.05 considered significant.
Results
In vitro culture of WD with surrounding mesonephros
Gene targeting techniques have enabled the identification of
critical molecules involved in kidney development, and it has
been found that several signaling systems including GDNF-Ret
system are operative in the WD budding process (Yu et al.,
2004). Nevertheless, the precise regulation of this process is not
understood. To clarify the mechanism of bud formation in more
detail, we employed an in vitro WD culture system. WDs were
isolated from E13 embryos together with surrounding meso-
nephros containing mesonephric ducts and were cultured on
Transwell filters for 4 days. No ectopic budding was induced in
the absence of growth factors (Fig. 1A). In contrast, in the
presence of GDNF, the ectopic budding structures could be
induced throughout the WD. The ectopic buds formed along the
WD at regular intervals (Fig. 1B). Quantitative analysis revealed
that numerous ectopic buds were induced at a concentration of
more than 10 ng/ml GDNF (Fig. 1C). Other members of the
GDNF family such as artemin, neutrin, or persephin had no
inductive effect (data not shown). WDs with surrounding
mesonephros isolated from E14 embryos had little capability
to bud in response to GDNF (data not shown), indicating
temporal restriction of this process to the earliest phase of
nephrogenesis. These findings are consistent with previous
reports regarding GDNF knockout mice (Sainio et al., 1997;
Sanchez et al., 1996), suggesting that this culture system is a
suitable model for analyzing the mechanism of bud formation.
Expression of activin subunits and activin receptors in the WD
and surrounding mesonephros
While many positive signals or genes have been found to be
involved in kidney development, little is known about the
negative regulation of WD budding, paracrine or autocrine.
Activin A, a member of TGF-β superfamily, is known to
negatively regulate UB branching (Bush et al., 2004; Maeshima
Fig. 1. Induction of ectopic buds from theWD by GDNF.WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS in the (A) absence or (B)
presence of 10 ng/ml GDNF for 4 days. Arrowheads indicate ectopic buds. Wolffian duct (WD), mesonephros (Meso). Scale bar: 200 μm. (C) Quantitative analysis of
WDs with ectopic buds. WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS in the presence of the indicated concentrations of GDNF
for 2 days. The number of the WDs forming ectopic buds was counted and was expressed as the percentage of total WDs tested (n = 4). Values are the mean ± SE of
three to five separate experiments. Note that there was no significant difference in the size of each bud and the number of the buds between the WDs treated with low
(10 ng/ml) and high (125 ng/ml) concentration of GDNF.
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in three-dimensional matrix (Maeshima et al., 2000b; Piscione
et al., 1997). However, the role of activin A in the process of UB
emergence from the WD is not clear. To address this issue, we
first examined the expression of activin subunits and activin
receptors in the WD and surrounding mesonephros of the E13
embryo. As shown in Fig. 2A, the βA subunit of activin was
detected in both WD and surrounding mesonephros by RT-
PCR. The βC and βE subunits were also detectable in the WD
as well as in the surrounding mesonephros, while the βB
subunit was detected only in the surrounding mesonephros.
Activin type I receptor (ActRI) and activin type II receptor
(ActRII) were expressed in both tissues.
Localization of activin A, activin receptors, and follistatin in
the WD and surrounding mesonephros
The localization of the members of activin signaling pathway
in the WD and surrounding mesonephros of the E13 embryo
was also studied by immunostaining (Fig. 2B). Immunoreactive
βA subunit of activin A was expressed in both the WD and
mesonephros. Both ActRIIA (data not shown) and ActRIIB
were expressed in the WD as well as surrounding mesonephros.
Follistatin was also detected in the WD and surrounding
mesonephros. The Smad2/3 protein, intracellular mediators of
activin signaling, was detected in the WD and surrounding
mesonephros (data not shown). Importantly, phospho-Smad2/3
protein was also detected in the nuclei of both tissues,
suggesting that the activin signaling pathway is normally
activated in both these tissues. Since the UB normally emergesfrom only a single site of the WD, the data presented here
suggest that this may be partly due to the persistent activation of
the activin signaling pathway in the WD.
Absence of activin A expression and phospho-Smad2/3 in
ectopic buds induced by GDNF
To further clarify if the activin signaling pathway is
involved in bud formation, we examined the expression of
activin A and phospho-Smad2/3 in the ectopic bud structures
of the WD. Consistent with E13 embryo-derived tissues (Fig.
2B), activin A was expressed in the WD as well as
mesonephros of the GDNF-untreated WD (data not shown).
In contrast, the expression of activin A was undetectable in
the ectopic buds of the GDNF-treated WD even though
strong staining was seen in the non-budded portion of the
WD (Fig. 2C). Phospho-Smad2/3 was also undetectable in
the WD in the presence of GDNF (Fig. 2C), while it was
detected in the WD as well as surrounding mesonephros in
the absence of GDNF (data not shown). We also analyzed the
expression of activin A and phospho-Smad2/3 in the E12
embryonic kidney, the stage of kidney development when the
UB emerges from the WD but does not form a T-shaped
structure yet. As observed in our WD culture model, activin
A was not detectable in the budding UB of the E12 embryo
(Fig. 2D), while the branching UB was found to express
activin A later in kidney development (data not shown) as
reported previously (Maeshima et al., 2003). These findings
suggest that activin signaling pathway is inactive in the
process of bud formation.
Fig. 2. Expression of activin subunits, activin receptors, follistatin and phospho-Smad2/3 in the WD and surrounding mesonephros. (A) Total RNA was
purified from the WD or surrounding mesonephros as described in Materials and methods. Gene expression of activin subunits and activin receptors was
examined by RT-PCR. (B) WDs with mesonephros were isolated and were fixed in 4% paraformaldehyde. Localization of βA subunit of activin A,
ActRIIB, follistatin, and phospho-Smad2/3 was examined by immunostaining. Nuclei (blue). Activin A, ActRIIB, follistatin, and phospho-Smad2/3 (red).
Wolffian duct (WD), mesonephros (Meso). Scale bar: 20 μm. (C) Expression of βA subunit of activin A and phospho-Smad2/3 in GDNF-treated WD. WDs
with mesonephros were cultured in DMEM/F12 medium containing 10% FBS with GDNF (125 ng/ml) for 2 days. Immunoreactive βA subunit of activin A
and phospho-Smad2/3 were detected by immunostaining. Activin A and phospho-Smad2/3 (red), nuclei (blue). White dotted line indicates ectopic buds.
Wolffian duct (WD), mesonephros (Meso). Scale bar: 50 μm. (D) Expression of βA subunit of activin A and phospho-Smad2/3 in the embryonic kidney.
Embryonic kidneys were isolated from E12 rat embryos and were fixed in 4% paraformaldehyde. Immunoreactive βA subunit of activin A and phospho-
Smad2/3 were detected by immunostaining. Activin A and phospho-Smad2/3 (red), nuclei (blue). Ureteric bud (UB), metanephric mesenchyme (MM). Scale
bar: 20 μm.
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activin A
To examine the role of endogenous activin A in bud
formation, we attempted to inactivate the action of activin A.
WDs with surrounding mesonephros were cultured with various
concentrations of GDNF in the presence of several neutralizing
antibodies (Fig. 3). We first examined the effect of blockade of
BMP4 action on the WD. In the presence of neutralizing anti-
BMP4 antibody, GDNF could induce ectopic bud formation at a
concentration of 5 ng/ml, a concentration at which no ectopic
buds could be induced by GDNF alone. These data are
consistent with a previous report regarding BMP4 knockout
mice (Miyazaki et al., 2000). Interestingly, a similar result was
obtained by blockade of activin A. Ectopic bud formation
occurred in the presence of 5 ng/ml GDNF with neutralizing
anti-activin A antibody, suggesting that, as in the case of BMP4,
blockade of activin A action increased the sensitivity of the WD
(cultured in the presence of mesonephros) to GDNF. A
neutralizing antibody against TGF-β (1,2,3) (data not shown)
or normal goat IgG had no effect on the WD cultured in the
presence of mesonephros. Taken together, it is possible that, like
BMP4, activin A acts as an endogenous inhibitory signal for
budding of the WD.
Inactivation of activin action is necessary for budding in the
cultured WD
To further clarify the precise role of activin A in bud
formation, we devised a new culture condition. WDs were
isolated from E13 rat embryo and were cultured on Transwell
filter in the absence of surrounding mesonephros. Unlike the
WD culture performed above in the presence of mesonephros,
GDNF alone could not induce ectopic budding structures inFig. 3. Increase of the sensitivity of the WD to GDNF by blockade of activin A.
WDs with mesonephros were cultured in DMEM/F12 medium containing 10%
FBS in the presence of GDNF (0, 1, 2.5, 5, 10, 25 ng/ml) with anti-activin A
antibody (2 μg/ml) or anti-BMP4 antibody (2 μg/ml) or normal goat IgG (2 μg/
ml) for 4 days. Quantification of the number of the WD with ectopic buds was
shown. Values are the mean ± SE of three to five separate experiments.the absence of mesonephros (Fig. 4A). When BMP4 action
was inactivated by the addition of an anti-BMP4 antibody or
the physiological antagonists, noggin or chordin, GDNF did
not induce any ectopic buds (Figs. 4A, B) and the WD
degenerated after 4 days under these culture conditions (data
not shown). A neutralizing anti-TGF-β antibody had no
inductive effect in the presence of GDNF (Fig. 4B). In
contrast, GDNF could induce ectopic buds in the presence of
the activin antagonist follistatin (Fig. 4A). GDNF induced
bud formation in the presence of more than 500 ng/ml
follistatin (data not shown), suggesting that endogenous
activin A inhibits bud formation. Consistent with this result,
when activin action was blocked by neutralizing anti-activin
A antibody or anti-ActRIB antibody, GDNF could induce
ectopic bud formation (Fig. 4A). DB lectin staining
demonstrated that the ectopically budding structures originat-
ed from the WD (Fig. 4A). There were no ectopic buds
observed in the presence of follistatin or these neutralizing
antibodies alone (Fig. 4B). Similar results were obtained by
bead experiments. Local inactivation of activin A action by
follistatin-soaked beads led to the formation of ectopic buds,
while there was no ectopic budding in the WD cultured with
BSA-soaked beads (Fig. 4C), GDNF being present under both
conditions.
We also tested the effect of gene knockdown of activin A by
siRNA on the WD (Fig. 5). Production of the βA subunit of
activin Awas reduced by approximately 50% in the WD treated
with activin siRNA (Fig. 5A). Significant reduction of activin
expression by siRNA treatment was also confirmed by real-time
PCR (Fig. 5B). In the control siRNA condition, ectopic buds
were not induced. In contrast, many ectopic buds were observed
in the activin siRNA-treated WD (Fig. 5C). Quantitative
analysis showed that the treatment of activin siRNA allowed
GDNF to induce ectopic buds (Fig. 5D). Taken together, these
findings support the possibility that UB outgrowth from the WD
is inhibited by endogenous activin A in an autocrine fashion.
Inhibition of GDNF-induced ectopic budding by activin A
The finding that blockade of activin action by multiple
independent approaches (natural antagonist, neutralizing anti-
bodies, and siRNA) allowed GDNF-induced ectopic budding
(Figs. 4, 5) suggests that activin A itself has a potential to inhibit
bud formation. To test this, we examined the effect of
exogenous activin A on GDNF-induced bud formation (Fig.
6A). When WDs with mesonephros were cultured in the
presence of GDNF with activin A, 1 ng/ml activin A showed
slight inhibitory effect on bud formation. In contrast, ectopic
budding was completely inhibited in the presence of 10 ng/ml of
activin A. Activin A but not activin B or activin AB
significantly inhibited GDNF-induced bud formation (Fig.
6B). Consistent with previous reports (Brophy et al., 2001;
Miyazaki et al., 2000), no ectopic budding occurred in the
presence of GDNF with BMP4. BMP4 (but not BMP2 or
BMP7) showed an inhibitory effect on bud formation (Fig. 6B).
On the other hand, induction of ectopic buds by GDNF was not
affected by addition of TGF-β1 (Fig. 6A).
Fig. 4. Induction of ectopic buds by blockade of activin A in culturedWDwithout mesonephros. (A)WDs were cultured in the absence of mesonephros in DMEM/F12
medium containing 10% FBS in the presence of the indicated factors for 4 days. GDNF (125 ng/ml), anti-BMP4 antibody (2 μg/ml), follistatin (500 ng/ml), anti-activin
A antibody (2 μg/ml), and anti-ActRIB antibody (2 μg/ml). Lower left panel: DB staining. Arrowheads indicate ectopic buds. Scale bars: 200 μm (50 μm in lower left
panel). (B) Quantitative analysis of theWDs with ectopic buds. Values are the mean ± SE of three to five separate experiments. (C) Induction of ectopic buds in theWD
by inactivation of local activin A. WDs were cultured in DMEM/F12 medium containing 10% FBS in the presence of GDNF (125 ng/ml) with BSA-soaked or
follistatin-soaked beads for 3 days. Arrowheads indicate ectopic buds. Scale bar: 200 μm.
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It is known that UB outgrowth is accompanied by cell
proliferation (Michael and Davies, 2004). To further clarify the
mechanism by which activin A inhibits bud formation, cell
proliferation was assessed by BrdU staining (Fig. 7A). In the
absence of GDNF, a number of BrdU-positive cells were
detected in the mesonephros after 2 days of culture. In the
presence of GDNF, a large number of BrdU-positive cells were
observed in budding structures. In contrast, BrdU-positive cells
were rarely detected in the WD in the presence of GDNF with
activin A or BMP4. Quantitative analysis showed that both
activin A and BMP4 significantly inhibitedWD proliferation but
did not affect cell proliferation in the mesonephros (Fig. 7B).
Apoptosis in the WD was not altered by activin A
Activin not only regulates cell growth and differentiation,
but it also induces programmed cell death in several types of
cells (Chen et al., 2002). To examine if activin A affects cell
apoptosis in the WD, we performed TUNEL staining (Fig. 7C).
In the absence of GDNF, a small number of TUNEL-positive
cells were detected in both the WD and mesonephros. In the
presence of GDNF, TUNEL-positive cells were mainly
observed in the WD. TUNEL-positive cells were also detectable
in the WD treated with activin A or BMP4. However, there was
no significant difference in the number of TUNEL-positive cellsbetween GDNF-treated WD with and without activin A or
BMP4 (Fig. 7D).
Reduction of Pax-2 expression by activin A
Pax-2 is one of the critical transcription factors involved in
kidney development (Dressler, 1996). It is believed that UB
outgrowth is regulated by Pax-2-dependent activation of GDNF
(Brophy et al., 2001). Ret expression was slightly reduced in
Pax-2 null mice (Brophy et al., 2001), suggesting that the
GDNF-Ret system is modulated by Pax-2 during budding
process. To investigate if Pax-2 is involved in the action of
activin A, we examined the expression of Pax-2 in the WD. The
expression of Pax-2 was detected in almost all nuclei of WD
cells in either the absence or the presence of GDNF (Fig. 8A). In
contrast, only a fraction of the WD cells expressed the Pax-2 in
the presence of GDNF with activin A (Fig. 8A) or BMP4 (data
not shown). Activin A significantly decreased the number of
Pax-2-positive cells in the WD (Fig. 8B).
Activation of PI3-kinase and MAP kinase pathway during bud
formation
We analyzed the downstream mediators of GDNF action in
this culture system (Fig. 9). GDNF signaling is known to be
mediated by its receptor GFRα1 and the receptor tyrosine
kinase Ret. Like other receptor tyrosine kinases, Ret can
Fig. 5. Induction of ectopic buds by activin siRNA in cultured WD. (A) Reduction of activin A production by siRNA. WDs were cultured in DMEM/F12 medium
containing 10% FBS in the presence of GDNF (250 ng/ml) with or without control siRNA or activin siRNA for 2 days. Production of βA subunit of activin A was
detected by Western blotting. The expression level of βA subunit was normalized to β-actin. (B) Reduction of βA subunit mRNA expression by siRNA. WDs were
cultured in DMEM/F12 medium containing 10% FBS in the presence of GDNF (250 ng/ml) with or without control siRNA or activin siRNA for 24 h. Expression level
of βA subunit of activin Awas measured by real-time PCR and was normalized to no treatment. Values are the mean ± SE (n = 3). (C) WDs were cultured in DMEM/
F12 medium containing 10% FBS in the presence of GDNF (250 ng/ml) with control siRNA or activin siRNA for 4 days. Scale bar: 200 μm. (D) Quantification of the
number of WDs with ectopic buds. Values are the mean ± SE (n = 5, *P < 0.05).
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support of a previous report regarding the involvement of
phosphatidylinositol (PI)-3 kinase in GDNF-induced bud
formation (Tang et al., 2002), phospho-Akt (a downstream
mediator of PI3-kinase) was detectable in the WD in the
presence of GDNF but not in the absence of GDNF.
Interestingly, phospho-p38 mitogen activated protein kinase
(MAPK) and phospho-extracellular signal-regulated kinase
(ERK) were also detected in the WD treated with GDNF but
not without GDNF. These findings suggest that both the PI3-
kinase and MAP kinase pathway are activated in the WD during
bud formation. In contrast, in the presence of GDNF with
activin A, the expression of these phospho-proteins was
significantly reduced in the WD.
Discussion
Using an in vitro WD culture system, we were able to
demonstrate that (1) the activin signaling pathway was normallyactive in the WD, (2) the expression of activin A as well as
phospho-Smad2/3 was absent in the ectopic buds, (3) blockade
of activin action increased the sensitivity of the WD to GDNF,
(4) blockade of activin action with a variety of agents
(follistatin, neutralizing antibodies, siRNA) allowed GDNF to
induce ectopic buds, and (5) activin A inhibition of GDNF-
induced bud formation was accompanied by the inhibition of
cell proliferation, the reduced expression of Pax-2, and the
decreased phosphorylation of PI3-kinase and MAP kinase in the
WD. Our data suggest that bud formation is inhibited by
endogenous activin A and that cancellation of activin action
might be a trigger for UB emergence from the WD.
Recent studies have enhanced our understanding of many
aspects of kidney development through in vivo, in vitro, and
transcriptional profiling studies. It is currently thought that
GDNF produced by the metanephric mesenchyme plays a major
role in UB outgrowth from the WD (Shakya et al., 2005).
GDNF-soaked beads can elicit ectopic UB formation when the
kidney rudiment is cultured together with the WD (Brophy et
Fig. 6. Inhibition of ectopic budding by activin A. (A) WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS in the presence of GDNF
(10 ng/ml) with 1 ng/ml or 10 ng/ml activin A or BMP4 (250 ng/ml) or TGF-β (2 ng/ml) for 4 days. Arrowheads indicate ectopic buds. Scale bar: 200 μm. (B)
Quantitative analysis of the WDs with ectopic buds. Values are the mean ± SE of three to five separate experiments.
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coreceptor GFRα1 as well as the receptor tyrosine kinase Ret.
Absence of GDNF or Ret leads to failure of UB outgrowth
(Sainio et al., 1997; Sanchez et al., 1996; Schuchardt et al.,
1996). In addition to the GDNF-Ret system, several growth
factors or transcription factors have been shown to be involved
in this process by gene targeting techniques, which include
BMP4 (Miyazaki et al., 2000), growth differentiation factor
(GDF)11 (Esquela and Lee, 2003), Six1 (Li et al., 2003), Eya1
(Xu et al., 1999), Sall1 (Nishinakamura et al., 2001), Pax-2
(Brophy et al., 2001), Sprouty1 (Basson et al., 2005), and the
Slit2/RoBo2 system (Grieshammer et al., 2004).
Although it is still unknown whether activin A interacts with
any of these pathways during bud formation, our findings raise
several possibilities. One possibility is that the activin signaling
pathway is involved in GDNF action during bud formation.
Activin Awas previously shown to act as an autocrine inhibitor
of branching tubulogenesis in an in vitro tubulogenesis model
(Maeshima et al., 2000b). Hepatocyte growth factor (HGF)
induced branching tubulogenesis in MDCK cells, which was
blocked by the addition of activin A. Blockade of activin action
by follistatin or overexpression of a mutant activin receptor
induced branching tubulogenesis qualitatively similar to that
induced by HGF. Thus, HGF may in part induce branching
morphogenesis by modulating the activin–follistatin system.
An analogous mechanism might be operative in our WD culture
model. We demonstrated that WDs expressed activin A and
activin receptors and that phospho-Smad2/3 was normally
detected in the WD (Figs. 2A, B). In contrast, the expression of
activin A was absent in the budding structures, and phospho-Smad2/3 was undetectable in the GDNF-treated WD (Fig. 2C),
suggesting the possibility that GDNF induces ectopic buds by
reducing the expression and/or secondary action of activin A.
We also showed that PI3-kinase as well as MAP kinase was
activated in the GDNF-treated WD (Fig. 9). Activated ERK by
receptor tyrosine kinases was previously reported to have the
ability to phosphorylate Smad and inhibit translocation of the
Smad protein into the nucleus (Kretzschmar et al., 1997).
Recently, Akt, a downstream mediator of PI3-kinase, was also
found to be able to bind directly to Smad and inhibit its activity
(Conery et al., 2004; Remy et al., 2004). Therefore, it is possible
that GDNF induces ectopic buds by inhibiting Smad function at
an intracellular level. Another possibility is that activin A
negatively regulates bud formation through the downregulation
of Pax-2, which is necessary for early steps in nephrogenesis.
Both GDNF and its receptor are considered to be target genes of
Pax-2 since not only the expression of GDNF but also that of
Ret was reduced in Pax-2 mutant mice (Brophy et al., 2001).
Pax-2 expression was reduced in the WD treated with activin A
(Fig. 8). Considering that the Smad binding element is present
in the promoter region of Pax-2 (Kuschert et al., 2001), it is thus
possible that activin A directly downregulates the transcription
of the Pax-2 gene.
Various mutant mice lacking genes encoding activin subunits
and receptors have been developed by homologous recombi-
nation: βA (Matzuk et al., 1995b), βB (Vassalli et al., 1994), βC
(Lau et al., 2000), βE (Lau et al., 2000), ActRII (Matzuk et al.,
1995a), and ActIIB (Oh and Li, 1997). However, there were no
reported kidney abnormalities in these mice. Nevertheless, it
has been reported that the number of glomeruli was increased
Fig. 7. Effect of activin A on cell proliferation and apoptosis in the WD. (A) Cell proliferation in activin-treated WD.WDs with mesonephros were cultured in DMEM/
F12 medium containing 10% FBS alone or in the presence of 50 ng/ml GDNFwith or without activin A (100 ng/ml) or BMP4 (250 ng/ml) for 2 days. Cell proliferation
was assessed by BrdU staining. BrdU-positive nuclei (green), DB (red), nuclei (blue). Scale bar: 50 μm. (B) Quantitative analysis of the number of BrdU-positive cells
in the WD (black bars) and surrounding mesonephros (white bars). Values are the mean ± SE (n = 5, **P < 0.01, ***P < 0.005). (C) Cell apoptosis in activin-treated
WD. WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS alone or in the presence of 50 ng/ml GDNF with or without activin A
(100 ng/ml) or BMP4 (250 ng/ml) for 2 days. Apoptosis was assessed by TUNEL staining. TUNEL-positive nuclei (green), DB (red), nuclei (blue). Scale bar: 20 μm.
(D) Quantitative analysis of the number of TUNEL-positive cells in the WD (black bars) and surrounding mesonephros (white bars). Values are the mean ± SE (n = 5,
**P < 0.01, NS, not significant).
Fig. 8. Reduction of Pax-2 expression in the WD by activin A. (A) WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS alone (Control)
or in the presence of GDNF (125 ng/ml) with or without activin A (100 ng/ml) for 2 days. Pax-2 was detected by immunostaining. Pax-2 (red), nuclei (blue). Scale bar:
20 μm. (B) Quantitative analysis of the number of Pax-2-positive cells. Values are the mean ± SE (n = 5, **P < 0.01).
482 A. Maeshima et al. / Developmental Biology 295 (2006) 473–485
Fig. 9. Phosphorylation of PI3-kinase and MAP kinase in theWD.WDs with mesonephros were cultured in DMEM/F12 medium containing 10% FBS alone (Control)
or in the presence of GDNF (125 ng/ml) with or without activin A (100 ng/ml) for 2 days. Phospho-Akt, phospho-p38, and phospho-ERK were detected by
immunostaining. Nuclei (blue), phospho-protein (red). Wolffian duct (WD), mesonephros (Meso). Scale bars: 50 μm.
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overexpressing activin mutant receptor (Maeshima et al.,
2000a). This phenotype may be due to the cancellation of the
inhibitory action of activin on UB branching, an idea that is
supported by studies in the isolated cultured UB (Bush et al.,
2004). Given that activin A is expressed in the WD at the early
stage of kidney development (Fig. 2) and has an inhibitory
effect on bud formation from the WD (Fig. 6), the kidney
phenotype found in these mutant mice is less than expected.
This may be partly due to the existence of multiple activin
subunits and redundancy in the activin signaling system (Chang
et al., 2001; Welt et al., 2002).
BMP4, another member of the TGF-β superfamily, has been
reported to act as an endogenous inhibitor of UB emergence
(Miyazaki et al., 2000). BMP4 is expressed in mesenchymal
cells surrounding the WD. In BMP4 knockout mice, ectopic
ureterovesical junction formation and double collecting systems
were found. Consistent with this report, we demonstrated that
BMP4 significantly inhibited ectopic budding induced by
GDNF (Fig. 6). Blockade of BMP4 action by a neutralizing
antibody increased the sensitivity of the WD to GDNF in
cultured WD with mesonephros (Fig. 3). However, there were
no ectopic buds induced by an anti-BMP4 neutralizing antibody
or BMP inhibitors in the cultured WD in the absence of
mesonephros (Fig. 4), most likely because BMP4 is mainly
produced by mesonephros and inhibits bud formation in a
paracrine manner. Given that activin A is also expressed in the
surrounding mesonephros at the time of UB emergence (Fig. 2),
activin A produced by the mesonephros may also inhibit bud
formation in a paracrine fashion. Nevertheless, in contrast toBMP4, blockade of activin action increased the sensitivity of
the WD to GDNF in cultured WD without surrounding
mesonephros (Figs. 4, 5), suggesting the autocrine action of
activin A. Taken together, these findings suggest that bud
formation is regulated by at least two kinds of negative
regulators, autocrine/paracrine activin A and paracrine BMP4.
Follistatin, an activin-binding protein, is a single chain
polypeptide which binds to activins with high affinity and blocks
their actions (Nakamura et al., 1990). Follistatin is expressed on
the surface of activin target cells by binding to the extracellular
matrix (Nakamura et al., 1991). Activins trapped by follistatin
are then internalized by endocytosis and subsequently degraded
by proteolysis (Hashimoto et al., 1997). We demonstrate here
that follistatin is expressed in both the WD and surrounding
mesonephros (Fig. 2), with a similar localization pattern to
activin A. This supports the possibility that the local action of
activin A is tightly regulated by follistatin in the budding
process. It was previously reported that follistatin can bind to
BMPs and modulate (inactivate or enhance) BMP action (Abe et
al., 2004; Amthor et al., 2002; Fainsod et al., 1997; Otsuka et al.,
2001), suggesting that the action of BMP4 in the WD is also
modulated by follistatin. The balance of activin or BMP4 and
follistatin might be important for the initiation of bud formation.
Mesenchymal tissues are required for the induction of
epithelial development. The normal cell proliferation of
epithelial tissues is generally thought to be stimulated by the
inductive interaction with the mesenchyme. In support of this
idea, we demonstrated that the mesonephros significantly
influences bud formation in our WD culture model. GDNF
alone induced ectopic buds in the WD with surrounding
484 A. Maeshima et al. / Developmental Biology 295 (2006) 473–485mesonephros present, but did not in the WD without
mesonephros. These results raise the possibility that the
mesonephros may produce a factor(s) required for GDNF to
exert its inductive effect. Such a factor(s) might have the
potential to modulate the sensitivity of the WD to GDNF.
Further study will be required to address this issue. The relative
balance of GDNF and activin A along the WD seems to be
important for determining the site of UB budding from the WD.
GDNF is produced by the metanephric mesenchyme at the time
of UB budding. In contrast, activin Awas expressed in the WD
and mesonephros but not in the UB or metanephric mesen-
chyme (Fig. 2), suggesting that GDNF action is dominant in the
metanephric mesenchyme. Given that activin A significantly
inhibited morphogenesis (Fig. 6) and proliferation of the WD
(Fig. 7), the dominant action of activin A in the mesonephros
may lead to degeneration of the other part of the WD during the
later stages of kidney development.
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